PBYI News Alert Puma Biotechnology (PBYI) 189.96 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Puma Biotechnology (PBYI) 189.96 $PBYI

NYSE stocks posting largest percentage decreases
AP - Tue Dec 23, 5:07PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
CRT: 18.91 (-0.53), RICE: 22.41 (-0.33), OCN: 14.88 (-0.14), GDOT: 20.42 (+0.25), PVG.TO: 5.91 (+0.20), UPL: 13.32 (-0.49), NSM: 28.77 (+1.59), VOC: 5.60 (-0.09), PVG: 5.07 (+0.14), PBYI: 189.96 (+0.12), GNI: 18.28 (+0.18), ANFI: 12.75 (+2.95)

Puma Biotechnology (PBYI) Jumps: Stock Moves 6.1% Up - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 8:39AM CST
Puma Biotechnology, Inc. (PBYI) was a big mover last session, as its shares rose over 6% on the day.
BIIB: 340.89 (+5.13), PBYI: 189.96 (+0.12)

SHAREHOLDER ALERT: Investigation on Behalf of Investors of Puma Biotechnology, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Fri Dec 19, 9:32AM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Puma Biotechnology, Inc. ("Puma" or the "Company" (NYSE BYI) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company concerning Puma's operations and financial prospects.
PBYI: 189.96 (+0.12)

Puma Biotechnology Reveals Positive Interim PB272 Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 2:20PM CST
Puma Biotechnology, Inc. (PBYI) announced interim safety and efficacy data on its oncology candidate, PB272 (neratinib) for HER2-positive metastatic breast cancer.
BIIB: 340.89 (+5.13), PFE: 31.42 (-0.03), AMGN: 160.67 (+3.15), PBYI: 189.96 (+0.12)

Top Healthcare Stocks for 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 14, 10:03AM CST
Source: Flickr user  Tax Credits . This past year has been a great one for healthcare investors -- the S&P healthcare index ETF offered double the return of the S&P 500. Biotechnology stocks dominated the list of the 10 top-performing...
MNK: 97.84 (-0.29), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), AGN: 210.12 (+0.95), VRTX: 115.15 (+1.40), ALNY: 93.52 (+0.97), EW: 130.75 (+1.17), ILMN: 186.22 (+2.72), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07), PBYI: 189.96 (+0.12)

Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data at 2014 CTRC-AACR San Antonio Breast Cancer Symposium
Business Wire - Fri Dec 12, 8:05AM CST
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that interim results from an ongoing Phase II clinical trial of Puma's investigational drug PB272 (neratinib) were presented at the 2014 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, Texas. The trial was supported by the National Comprehensive Cancer Network(R), ASCO's Young Investigator Award, Susan G. Komen for the Cure(R), and the Terri Brodeur Breast Cancer Foundation. The presentation is further detailed below.
PBYI: 189.96 (+0.12)

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Puma Biotechnology, Inc.
Business Wire - Wed Dec 10, 11:38AM CST
Levi & Korsinsky, LLP is investigating Puma Biotechnology, Inc. (NYSE BYI) in connection with possible violations of federal securities laws by the Board of Directors of the Company.
PBYI: 189.96 (+0.12)

INVESTOR ALERT: Investigation of Puma Biotechnology, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Tue Dec 09, 5:49PM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Puma Biotechnology, Inc. ("Puma" or the "Company" (NYSE BYI) concerning possible violations of federal securities laws. The investigation is focused on certain statements issued by Puma concerning the Company's operations and financial prospects.
PBYI: 189.96 (+0.12)

Hawaiian Electric and Taser are big market movers
AP - Thu Dec 04, 3:35PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
TSLA: 222.26 (+1.29), HE: 33.35 (+0.17), PLUG: 3.05 (-0.01), CLV: 5.53 (-0.10), CLF: 6.06 (-0.09), BKS: 23.46 (+0.38), ARO: 2.30 (-0.03), RAD: 7.26 (-0.09), CARB: 14.54 (+0.94), SQNM: 3.59 (-0.01), ENB.TO: 58.86 (+0.09), RIG: 18.77 (-0.37), IDRA: 3.89 (+0.02), ANF: 28.06 (-0.17), ENB: 50.63 (+0.16), TASR: 26.86 (+0.84), AVGO: 100.72 (-0.06), PBYI: 189.96 (+0.12)

Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.
PR Newswire - Thu Dec 04, 12:21PM CST
Avanir Pharmaceuticals, Inc.
CARB: 14.54 (+0.94), AVNR: 16.91 (+0.01), RLD: 11.35 (+0.02), NYMX: 0.38 (unch), CASY: 89.15 (+0.12), PBYI: 189.96 (+0.12), CODE: 34.55 (+0.64)

How to Make Money in Biotech Stocks
Diana Gordon - Daily Reckoning - Wed Dec 03, 4:25PM CST
This post How to Make Money in Biotech Stocks appeared first on Daily Reckoning . Biotech stocks delivered triple-digit returns throughout the ’80s and ’90s. But it’s been a decade since we’ve seen similar results. Investment director Paul...
ICPT: 151.49 (+5.85), PBYI: 189.96 (+0.12)

Puma Biotechnology Down on Delay in Neratinib NDA Filing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 4:10PM CST
Shares of Puma Biotechnology, Inc. (PBYI) plunged significantly in after-market hours trading following the company's announcement that the NDA on pipeline candidate neratinib (PB272) will be delayed till the first quarter of 2016.
BIIB: 340.89 (+5.13), PFE: 31.42 (-0.03), PBYI: 189.96 (+0.12)

Stocks Close Higher, Helped by Continued Strength in Economy
at The Street - Wed Dec 03, 3:19PM CST
The S&P 500 inched to another record high Wednesday after the release of the Federal Reserve's Beige Book showed the economy is still gaining strength.
GIII: 99.53 (+1.82), HAL: 39.70 (-0.18), BOBE: 50.58 (-0.04), ILMN: 186.22 (+2.72), SLB: 87.06 (-0.26), SQNM: 3.59 (-0.01), JCP: 6.50 (-0.24), BP: 38.95 (-0.17), PBYI: 189.96 (+0.12), XLE: 80.13 (-0.59)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc.
PR Newswire - Wed Dec 03, 1:34PM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Puma Biotechnology, Inc. ("Puma Biotechnology" or the "Company" (NYSE: PBYI -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
PBYI: 189.96 (+0.12)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI
PR Newswire - Wed Dec 03, 1:21PM CST
Pomerantz LLP is investigating claims on behalf of investors of Puma Biotechnology, Inc. ("Puma" or the "Company" (NYSE: PBYI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
PBYI: 189.96 (+0.12)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 11:45AM CST

GLOG: 20.40 (-0.98), MILL: 1.23 (-0.07), LPHI: 0.70 (+0.02), NEOT: 6.65 (+0.25), BOBE: 50.58 (-0.04), FES: 1.19 (-0.01), REDF: 2.09 (unch), NKTR: 15.02 (+0.23), PRTO: 10.40 (+0.17), CANF: 3.70 (+0.01), CALI: 1.19 (+0.05), TRT: 2.92 (unch), SQNM: 3.59 (-0.01), CARB: 14.54 (+0.94), SEED: 1.33 (-0.03), BLFS: 1.79 (-0.02), DGLY: 15.62 (+0.82), TCCO: 4.96 (-0.04), ALCO: 49.88 (-0.50), PBYI: 189.96 (+0.12)

Puma Biotech Stock Plunges On Drug Filing Delay
at Investor's Business Daily - Wed Dec 03, 10:43AM CST
Shares of Puma Biotechnology were down 14% to around 193 in morning trading on the stock market today after the company said late Tuesday that it will file for FDA approval of its first drug a year later than expected. Puma (PBYI) said that it will...
PFE: 31.42 (-0.03), PBYI: 189.96 (+0.12)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 107

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 53

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 70

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 119

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Microinsurance Market Expected to Surpass $11 Billion by 2034

Updated Category News Views 137

Growth Trajectory of the Global Microinsurance Market The microinsurance market is witnessing remarkable transformation as consumer demands shift towards financial inclusion, coupled with increasing awareness of the myriad advantages insurance provides. This positive trend is fueled by government initiatives aimed at regulation and expansion of microinsurance offerings,...

Continue Reading
Ormat Technologies Launches Secondary Stock Offering

Updated Category News Views 188

Ormat Technologies Launches Secondary Stock Offering Ormat Technologies, Inc. (NYSE: ORA), renowned for its innovative geothermal and renewable energy solutions, recently announced an exciting development in the investment realm—the initiation of an underwritten secondary offering. This offering encompasses a total of 3,700,000 shares of common stock on behalf of ORIX...

Continue Reading
MongoDB Executive Share Transactions Highlight Growth Potential

Updated Category News Views 132

Insights from MongoDB Executive Share Transactions Cochran Hope F, a director at MongoDB, Inc. (NASDAQ: MDB), recently made notable moves with the company's Class A Common Stock, and these transactions were disclosed in the latest SEC filings. This activity has attracted attention from investors. In September, the director sold 1,174 shares at $224.38 each, which brought...

Continue Reading
Essential Guidance for Navigating Hurricane Travel Risks

Updated Category News Views 69

Essential Guidance for Navigating Hurricane Travel Risks Hurricane season brings with it the potential for severe weather that can disrupt travel plans and lead to significant financial losses. As storms like Hurricane Helene have shown, the impact can be widespread, devastating homes and infrastructure, particularly in the southeastern regions. During these turbulent...

Continue Reading
Ascend Performance Materials Launches High-Purity Production

Updated Category News Views 279

Ascend Performance Materials Starts High-Purity Acrylonitrile Production Ascend Performance Materials has recently announced an exciting new phase in its production capabilities. The company is now producing high-purity acrylonitrile at its Chocolate Bayou facility. This advancement comes after the successful installation and commissioning of state-of-the-art purification...

Continue Reading